US Patent Issued to NantBio on Dec. 23 for "Conditional modulation of therapy using recombinant cells" (California Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,404, issued on Dec. 23, was assigned to NantBio Inc. (Culver City, Calif.).

"Conditional modulation of therapy using recombinant cells" was invented by Clifford Anders Olson (Culver City, Calif.), Kayyan Niazi (Culver City, Calif.), Nicholas J. Witchey (Culver City, Calif.) and Wael Tadros (Culver City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to recombinant therapeutic cells comprising recombinant sensor proteins, such that a therapeutic molecule is expressed after the occurrence of two separate triggering events that are sensed by the sensor proteins. Nucleic acids, kits, and methods for making and using...